Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230812 | SCV000289565 | benign | Brugada syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000438285 | SCV000520916 | benign | not specified | 2016-10-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV002274943 | SCV002563758 | benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | SCN10A: BS1, BS2 |
Ambry Genetics | RCV002338748 | SCV002641900 | benign | Cardiovascular phenotype | 2018-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000438285 | SCV005204736 | likely benign | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002274943 | SCV005238233 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000438285 | SCV001920710 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000438285 | SCV001956776 | benign | not specified | no assertion criteria provided | clinical testing |